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Abstract
Background: Flexible bronchoscopy with bronchial washing is a useful procedure for diagnosis of pulmonary
tuberculosis (TB), when a patient cannot produce sputum spontaneously or when sputum smears are negative.
However, the benefit of gaining serial bronchial washing specimens for diagnosis of TB has not yet been studied.
Therefore, we conducted a retrospective study to determine the diagnostic utility of additional bronchial washing
specimens for the diagnosis of pulmonary TB in suspected patients.
Methods: A retrospective analysis was performed on 174 patients [sputum smear-negative, n = 95 (55%); lack of
sputum specimen, n = 79 (45%)] who received flexible bronchoscopy with two bronchial washing specimens with
microbiological confirmation of pulmonary TB in Samsung Medical Center, between January, 2010 and December,
2011.
Results: Pulmonary TB was diagnosed by first bronchial washing specimen in 141 patients (81%) out of 174
enrolled patients, and an additional bronchial washing specimen established diagnosis exclusively in 22 (13%)
patients. Smear for acid-fast bacilli (AFB) was positive in 46 patients (26%) for the first bronchial washing specimen.
Thirteen patients (7%) were positive only on smear of an additional bronchial washing specimen. Combined smear
positivity of the first and second bronchial washing specimens was significantly higher compared to first bronchial
washing specimen alone [Total cases: 59 (34%) vs. 46 (26%), p < 0.001; cases for smear negative sputum: 25 (26%)
vs. 18 (19%), p = 0.016; cases for poor expectoration: 34 (43%) vs. 28 (35%), p = 0.031]. The diagnostic yield
determined by culture was also significantly higher in combination of the first and second bronchial washing
specimens compared to the first bronchial washing. [Total cases: 163 (94%) vs. 141 (81%), p < 0.001; cases for smear
negative sputum: 86 (91%) vs. 73 (77%), p < 0.001; cases for poor expectoration: 77 (98%) vs. 68 (86%), p = 0.004].
Conclusions: Obtaining an additional bronchial washing specimen could be a beneficial and considerable option
for diagnosis of TB in patients with smear-negative sputum or who cannot produce sputum samples.
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Background
Pulmonary tuberculosis (TB) is a major public health
challenge worldwide, with an estimated 8.8 million new
cases and 1.45 million TB-related deaths in 2010 [1]. Al-
though various diagnostic tests for pulmonary TB have
been developed, its definitive diagnosis still relies on cul-
turing Mycobacterium tuberculosis (M. tuberculosis)
from respiratory secretions. For sputum samples, inter-
national guidelines recommend obtaining at least two
specimens from patients with suspected tuberculosis to
increase the diagnostic sensitivity for identification of M.
tuberculosis [2]. In patients with negative sputum smear
or who cannot produce sputum samples, previous stud-
ies have proved efficacy of an alternative method of
obtaining respiratory samples by bronchoscopy in diag-
nosis of TB [3-8]. However, it is yet known whether an
additional bronchial specimen acquired from bronchial
washing has an incremental diagnostic yield for diagno-
sis of TB as second and third sputum samples have
[9-11]. Therefore, the aim of this study was to assess the
diagnostic value of the second bronchial washing se-
quentially obtained after the first bronchial washing spe-
cimen in suspected pulmonary TB patients who are




This was a retrospective observational study on the role
of additional bronchial washing specimens in diagnosis
of TB in Samsung Medical Center (a 1960-bed,
university-affiliated, tertiary referral hospital in Seoul,
South Korea) between January 2010 and December
2011. TB case is clinically suspected as a patient cur-
rently not receiving tuberculosis treatment with a per-
sistent cough for >3 weeks or symptoms consistent with
TB (chest pain, low-grade fever, night sweats, shortness
of breath, and weight loss) with chest radiograph or
computed tomograph scan suggestive of pulmonary TB.
In clinically suspected TB patients with smear-negative
sputum or who are difficult to produce sputum samples,
we obtain three serial bronchial washing samples during
bronchoscopy.
Of those who underwent bronchoscopy with two
bronchial washing specimens for AFB smear and culture,
we recruited 225 patients with a microbiological con-
firmation of M. tuberculosis during the study period. Of
those patients, 51 receiving tuberculosis treatment be-
fore bronchoscopy were excluded from the study. This
left a population of 174 patients with a diagnosis of pul-
monary tuberculosis from bronchial washing (n = 163);
other methods, such as pathologic confirmation with
culture from tissue obtained by bronchoscopy, (n = 4);
nucleic acid amplification assay for M. tuberculosis on
the third bronchial washing (n = 2); and sputum culture
(n = 5) (see Figure 1). Demographic, clinical and radio-
logical variables were determined by retrospective ana-
lysis of medical records. The Institutional Review Board
of Samsung Medical Center approved the review and
publication of data obtained from the patients’ records
(Protocol No: 2011-07-037) and the study was
conducted in compliance with the Helsinki Declaration.
Informed consent was waived due to the retrospective
nature of this study.
Bronchoscopy procedures
Bronchoscopy with bronchial washing was performed
according to the standard technique as described previ-
ously [12,13]. Patients were sedated with intravenous
midazolam. Under conscious sedation, the bronchoscope
(Olympus, Tokyo, Japan) was inserted trans-nasally or -
orally and lidocaine of 5 mL to 10 mL as needed was
sprayed intratracheally. After placing bronchoscope at
the targeted segment, bronchial washing was performed
by instilling 10 mL of warm sterile saline. Several breaths
were allowed for the fluid to pool at the target segment
before retrieval. This procedure was repeated twice at
the same segment. Each retrieved sample was labeled as
the first, second, and third sample. First and second
samples were then tested for acid-fast bacilli (AFB) by
smear and culture. The third specimen was subjected to
a nucleic acid amplification assay for M. tuberculosis
[14,15]. When multiple pulmonary infiltrates were vis-
ible on chest radiography, bronchial washing was
performed at the segment exhibiting the most severe
abnormalities.
Microbiological examination
Aliquots of specimens were decontaminated with the
2% N-acetyl-L-cysteinhydroxide (NALC-NaOH). Then
the specimens were stained by auramine-rhodamine
fluorescent and Ziehl-Neelsen stain and examined under
microscopy. The processed specimens were also plated
onto both 3% Ogawa solid medium (Shinyang, Seoul,
Korea) and liquid culture medium (MGIT 960 system,
Becton Dickinson, Sparks, MD, USA) and were incubated
at 36°C for 6 weeks. Nucleic acid amplification test for
M. tuberculosis was performed using COBAS TaqMan MTB
assay (Roche Diagnostics, Basel, Switzerland) according to the
manufacturer’s guideline.
Definition
Microbiological confirmation of M. tuberculosis was de-
fined as growth of M. tuberculosis or positive test result
of the nucleic acid amplification for M. tuberculosis from
respiratory or tissue samples. Immunocompromised
condition was defined as following: undergoing chemo-
therapy for an malignancy within 4 weeks, being
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seropositive for human immunodeficiency virus or
undergoing daily administration of systemic corticoste-
roids (at least 20 mg prednisolone or equivalent for
more than 1 month), combination therapy with low dose
corticosteroids and other immunosuppressants including
azathioprine, mycophenolate, methotrexate, cyclospor-
ine, or cyclophosphamide or under status of solid or
hematologic transplantation.
Statistical analysis
All data are presented as numbers (percentages) for cat-
egorical variables and as medians with interquartile
ranges (IQR) for continuous variables. The diagnostic
yield of repeated bronchial washing for the diagnosis of
TB was determined. The diagnostic consistency
according to the number of bronchial washing was ana-
lyzed using the McNemar’s test. Diagnostic yield and
diagnostic consistency were also sub-analyzed based on
the reason of bronchoscopy. To identify the factors to
predict diagnostic yield according to the number or
order of bronchial washing specimens, clinical and la-
boratory characteristics according to positivity of first
and/or second bronchial washing specimens were com-
pared using the Kruskal-Wallis test for continuous vari-
ables and the χ2 test for categorical variables. Statistical
analyses were performed using IBM SPSS Statistics 21.0
(IBM, Chicago, IL, USA), and two-sided P < 0.05 was
considered significant.
The incremental yield of an additional bronchial washing
specimen was defined as [(number of cases additionally
diagnosed by second bronchial washing specimen/number
of all diagnosed cases) × 100] [16].
Results
The baseline characteristics of the patients are summarized
in Table 1. There were 90 males and 84 females, with a me-
dian age of 53 (IQR 34–68) years. Seventy six (44%) pa-
tients had one or more comorbidities and 32 (18%) had
undergone previous TB treatment. The most common pre-
senting symptoms were cough (n = 43, 25%) and sputum
(n = 23, 13%). Chest radiographs were available for analysis
in all patients. The most common radiologic finding was
small nodules (n = 95, 55%), followed by consolidation
(n = 45, 26%), atelectasis (n = 19, 11%), and cavitation
(n = 18, 10%). The most common sites at which bronchial
washing was performed were the right upper lobe (n = 71,
41%) and the left upper lobe (n = 49, 28%). Regarding ad-
verse events, five patients (2.9%) had fever after bronchos-
copy and one (0.6%) had tachycardia, which resolved after
bronchoscopy.
Out of 174 study patients, 46 (26%) patients had a
positive AFB smear in the first bronchial washing speci-
men, and additional 13 (7%) patients had a positive AFB
smear only in the second bronchial washing specimen.
Nucleic acid amplification assay for M. tuberculosis
using the third bronchial washing was positive in 72
(41%) patients and was the sole method to diagnose pul-
monary TB in 2 patients. Combined smear positivity of
the first and second bronchial washing specimens was
significantly higher than that of the first bronchial
Figure 1 Diagnostic flow of 174 study patients. BW, bronchial washing; NAA = nucleic acid amplification.
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washing specimen alone [59 (34%) vs. 46 (26%), p <
0.001]. (Figure 2) On culture, M. tuberculosis was identi-
fied in 141 (81%) patients by first bronchial washing spe-
cimen. Additional bronchial washing specimen identified
M. tuberculosis exclusively in 22 (13%) patients. The
diagnostic yield of culture was also significantly higher
in combination of the first and second bronchial wash-
ing specimens compared to the first bronchial washing
[163 (94%) vs. 141 (81%), p < 0.001]. (Figure 3).
Diagnostic yield was assessed based on the reason of
bronchoscopy. Out of 95 patients with smear-negative
sputum, 18 patients (19%) had a positive AFB smear in
the first bronchial washing and an additional seven (7%)
had a positive AFB smear from the second bronchial
washing. Combined smear positivity of the first and sec-
ond bronchial washing specimens was higher than that
of first bronchial washing specimen alone [25 (26%) vs.
18 (19%), p = 0.016]. (Figure 2) On culture, M. tubercu-
losis was identified in 73 patients from the first bronchial
washing and 86 patients had pulmonary TB on culture
from combination of the first and second bronchial
washing [86 (91%) vs. 73 (77%), p < 0.001]. (Figure 3)
The incremental yield of culture positive cases was 14%
with the additional second bronchial washing. Of 79 pa-
tients who were unable to expectorate, an AFB smear by
direct microscopy was positive in 28 patients (35%) for
the first bronchial washing and six (8%) were positive
upon an additional bronchial washing smear. Cultures
positive for M. tuberculosis were obtained in 68 patients
(86%) using first bronchial washing specimens, and the
first or second bronchial washing specimen was diagnos-
tic in 77 patients (98%). Accordingly, the incremental
yield from the second bronchial washing was 11%. The
diagnostic yield for smear and culture of the combined
bronchial washing specimens were significantly higher
compared to the first bronchial washing specimen
[smear: 34 (43%) vs. 28 (35%), p = 0.031; culture: 77
(98%) vs. 68 (86%), p < 0.001]. (Figure 2 and 3).
A drug susceptibility test was performed in 172 pa-
tients, excluding two who were diagnosed by a positive
nucleic acid amplification test without culture of M. tu-
berculosis. Of 141 patients first bronchial washing of
whom was cultured, 20 had drug-resistant tuberculosis
(13 had multi-drug resistance (MDR) and seven had iso-
niazid (INH) resistance (INH-R)). The second bronchial
washing identified seven additional patients with drug–
resistant tuberculosis (four with MDR including one
with extensive drug-resistance (XDR) and three with
INH–R).
Table 2 shows comparisons of the clinical and radio-
logical characteristics of patient groups with a positive
result only on the first bronchial washing, only on the
second bronchial washing, and in both bronchial wash-
ings (n = 163). There were no significant factors to
Table 1 Baseline characteristics of 174 study patients
No. of patients (%) or median (IQR)
Age, years 53 (34 – 68)
Gender, female 84 (48)
Comorbidity 76 (44)
Malignancy 31 (18)
Cardiovascular disease 29 (17)
DM 25 (14)
Chronic hepatitis 3 (2)
Respiratory disease 4 (2)





Current smoker 41 (24)
















Fibrotic scar 8 (5)
Normal 3 (2)
Location of bronchial washing
Right upper lobe 71 (41)
Right middle lobe 19 (11)
Right lower lobe 25 (14)
Left upper lobe 49 (28)
Left lower lobe 10 (6)
Abbreviations: IQR, interquartile ranges; DM, diabetes mellitus; TB, tuberculosis.
* Hyperthyroidism (n = 2), hypothyroidism (n = 1), paraplegia due to spinal
cord injury (n = 1), Klippel-Feli syndrome (n = 1), osteoporosis (n = 1).
Categorical variables were denoted by No. of patients (%).
Continuous variable was denoted by median (IQR).
Yoo et al. BMC Infectious Diseases 2013, 13:404 Page 4 of 8
http://www.biomedcentral.com/1471-2334/13/404
predict diagnostic yield according to the number or
order of bronchial washing specimens, including age,
gender, comorbidities, smoking history, previous TB his-
tory or immune status. There were also no significant
differences among groups regarding radiographic find-
ings, as well.
Disscusion
To our knowledge, this is the first study of the diagnos-
tic value of an additional bronchial specimen acquired
after the first bronchial washing. This retrospective study
demonstrated that the diagnosis of pulmonary tubercu-
losis was increased by up to 13% with second bronchial
washings in subjects whose spontaneous sputum was
smear negative or who could not produce spontaneous
sputum. In addition, second bronchial washing specimen
identified additional drug-resistant M. tuberculosis in 7
patients (four MDR pathogens including one XDR and
three INH-R pathogens).
It is well recognized that the smear positivity yield in
sputum increases as the number of sputum samples in-
creases in patients suspected as having pulmonary TB. A
large study conducted in Tanzania showed that an incre-
mental yield of 83.4% with the first, 12.2% with the sec-
ond, and 4.4% with the third smear was estimated for
the total number of expected cases (combined suspects
with a complete set of three sputum smears examined
and one with an incomplete examination) [11]. In
Malawi, all TB suspects submit three sputum specimens
for smear examination and the diagnosis is made by the
first specimen in 83%, the second specimen in 13%, and
the third specimen in 4% of patients [17]. Given the high
Figure 2 Smear positive yield of single bronchial washing and two consecutive bronchial washing specimens. BW, bronchial washing.
Figure 3 Culture positive yield of single bronchial washing and two consecutive bronchial washing specimens. BW, bronchial washing.
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diagnostic yield of over 10% in the second sputum smear
[18] and the cost-effectiveness of obtaining the third
specimen in low-income countries, [19] international
guidelines recommend to obtain at least two sputum
specimens from patients with suspected tuberculosis to
increase the diagnostic yield for identification of M.
tuberculosis [2]. In line with previous studies that used
serial sputum samples, [11,17,18] our findings demon-
strated for the first time a 13% culture incremental yield
from an additional bronchial washing compared with
performing only a single bronchial washing in patients
with smear-negative sputum or in those in whom spu-
tum was unavailable. Although no other reports or uni-
versal cut-off values are available for comparison with
our results, we believe that an incremental culture rate
of 13% for the second bronchial washing highlights the
importance of additional bronchial washings.
In our study, consecutive first and second bronchial
washings provided high TB diagnostic yield in patients who
were negative on sputum smear microscopy or were unable
to expectorate sputum; culture for M. tuberculosis was
positive in 163 of 174 patients (94%). When our patients
were divided according to the reason for performance of
bronchoscopy, 77% of those who were negative on sputum
smear microscopy were culture-positive in the first bron-
chial washing, which is consistent with previous reports of
a positivity rate of 65-78% for culture of a single bronchial
washing [7,8]. Use of a second bronchial washing added 8%
to the positivity rate of culture for diagnosis of pulmonary
TB, leading to a diagnostic yield of 85% of suspected TB pa-
tients with smear-negative sputum. In patients who were
unable to expectorate sputum, however, few studies have
focused on the diagnostic power of bronchial washing,
while our data showed that consecutive first and second
bronchial washings led to a rapid diagnosis in 43% by mi-
croscopy smear and accounted for the culture positivity of
77 of 79 patients (98%). Thus, these data indicate the diag-
nostic importance of bronchial washing in patients who
lack spontaneous sputum for TB diagnosis.
In our study, the yield of M. tuberculosis culture was
almost three times that of AFB smears, confirming the
importance of culture for the diagnosis of pulmonary TB
in our patients. In an era of increasing drug resistance,
isolation of M. tuberculosis from respiratory specimens
is important for drug sensitivity test. Additional 7 (26%
of all drug- resistant TB) patients have been confirmed
to have drug-resistant tuberculosis in the present study
by means of further secondary bronchial washing. It in-
dicates that an additional bronchial washing is a mean-
ingful process not only in increasing the diagnostic yield
but also in obtaining M. tuberculosis strain which allows
drug susceptibility test.
For patients with positive results for M. tuberculosis
from bronchial washing, there are no specific clinical or
Table 2 Comparisons of the clinical and radiological characteristics according to positive result in serial bronchial
washing specimens in 163 patients*
BW1 (+) (n = 30) BW2 (+) (n = 22) BW1 & 2 (+) (n = 111) P value
Age, years 54 (34 – 71) 60 (29 – 71) 52 (34 – 68) 0.898
Gender, female 11 (37) 12 (54) 57 (51) 0.310
Presence of Comorbidity 11 (37) 10 (46) 51 (46) 0.657
Immunocompromised patients 1 (3) 1 (5) 11 (10) 0.407
Current of ex- smoker 12 (40) 9 (41) 42 (38) 0.951
Previous history of treatment TB 5 (17) 4 (18) 23 (21) 0.869
Clinical Symptom 13 (43) 8 (36) 51 (46) 0.707
No symptoms 17 (57) 14 (64) 60 (54) 0.707
Chest radiology
Fibrotic scar 1 (3) 0 6 (5) 0.500
Cavitation 3 (10) 5 (23) 10 (9) 0.169
Nodules 16 (53) 17 (77) 58 (52) 0.093
Mass 5 (17) 0 7 (6) 0.057
Consolidation 6 (20) 3 (14) 34 (31) 0.174
Atelectasis 1 (3) 3 (14) 13 (12) 0.358
Effusion 1 (3) 1 (5) 6 (5) 0.894
Drug resistance 3 (10) 7 (32) 17 (15) 0.092
BW, Bronchial washing.
Categorical variables were denoted by No. of patients (%).
Continuous variable was denoted by median (IQR).
*Patients with positive results for M. tuberculosis from bronchial washing.
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radiologic parameters which can determine who needs
second bronchial washing. The reported adverse events
associated with the procedure were tolerable. Further-
more, the inhibitory effect of lidocaine on the growth of
M. tuberculosis might contribute to the false negative
rate and/or relatively low colony counts of M. tubercu-
losis from first bronchial washing specimens [20]. Thus,
we suggest that obtaining two serial bronchial samples is
safe and reasonable during performance of bronchos-
copy in patients with smear-negative sputum or in those
who cannot produce sputum samples.
To fully appreciate these results, the limitations of this
study must be acknowledged. First, given the retrospect-
ive design of this study, it is possible that selection bias
influenced our findings. A prospective study would be
needed to fully validate these promising findings. Add-
itionally, the increased yield of TB diagnosis in our study
might have been related to larger cumulative volume ra-
ther than the repeated washing process. A prospective
study comparing separate bronchial washings and single
bronchial washing with the same amount of total saline
is required to address this question. Third, our study
was conducted at a single institution in an area of inter-
mediate TB burden (incidence of TB, 97 per 100,000),
which might limit the application of our findings, espe-
cially in areas of differing TB prevalence. Finally, we
were unable to evaluate the economic cost associated
with the study protocol or the counterproductive effects
of overburdened technicians. High costs and technician
shortages may limit the use of bronchoscopy in other
situations.
Conclusions
In summary, we found that obtaining additional second
bronchial washing sample increased the diagnostic yield
by up to 13% under tolerable adverse events. This sug-
gests that two serial bronchial washings are a beneficial
and reasonable option for detection of TB and evalu-
ation of drug resistance in patients who have negative
AFB smears or who are unable to produce sputum sam-
ples in intermediate TB-burden countries.
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